• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Inflammatory myofibroblastic tumor of the lung - an explosive metastatic case.

作者信息

Rodrigues Henrique Cabrita, Videira Wanda, Rodrigues Luís, Pinheiro Rita, Ferro Filipa

机构信息

. Serviço de Pneumologia, Centro Hospitalar Universitário Lisboa Norte, Lisboa, Portugal.

出版信息

J Bras Pneumol. 2022 Dec 19;48(5):e20220127. doi: 10.36416/1806-3756/e20220127.

DOI:10.36416/1806-3756/e20220127
PMID:36629632
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9747178/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3945/9747178/415b7e7f276a/1806-3756-jbpneu-48-05-e20220127-gf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3945/9747178/415b7e7f276a/1806-3756-jbpneu-48-05-e20220127-gf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3945/9747178/415b7e7f276a/1806-3756-jbpneu-48-05-e20220127-gf1.jpg

相似文献

1
Inflammatory myofibroblastic tumor of the lung - an explosive metastatic case.肺炎性肌纤维母细胞瘤——1例暴发性转移病例
J Bras Pneumol. 2022 Dec 19;48(5):e20220127. doi: 10.36416/1806-3756/e20220127.
2
[Inflammatory myofibroblastic tumor of the lung: histopathology and imaging findings].[肺炎性肌纤维母细胞瘤：组织病理学与影像学表现]
Tuberk Toraks. 2020 Sep;68(3):321-327. doi: 10.5578/tt.69793.
3
Large Inflammatory Myofibroblastic Tumor of the Lung in a Pediatric Patient.
Arch Bronconeumol. 2024 Feb;60(2):103-104. doi: 10.1016/j.arbres.2023.11.002. Epub 2023 Nov 9.
4
Inflammatory myofibroblastic tumor (inflammatory fibrosarcoma) of the bone.
Arch Pathol Lab Med. 2000 Oct;124(10):1514-7. doi: 10.5858/2000-124-1514-IMTIFO.
5
Invasive inflammatory myofibroblastic tumor of the lung.肺侵袭性炎性肌纤维母细胞瘤
J Thorac Oncol. 2009 Jul;4(7):923-6. doi: 10.1097/JTO.0b013e3181a76e28.
6
Progression of inflammatory myofibroblastic tumor (inflammatory pseudotumor) of soft tissue into sarcoma after several recurrences.
Hum Pathol. 1996 Oct;27(10):1095-8. doi: 10.1016/s0046-8177(96)90291-9.
7
Inflammatory myofibroblastic tumor of the lung: recurrence after steroid treatment.肺炎性肌纤维母细胞瘤：类固醇治疗后复发
J Thorac Imaging. 2008 Aug;23(3):191-3. doi: 10.1097/RTI.0b013e31816591a4.
8
Inflammatory Myofibroblastic Tumours of the Respiratory Tract: A Series of Three Cases with Varying Clinical Presentations and Treatment.呼吸道炎性肌纤维母细胞瘤：三例不同临床表现及治疗的病例系列
Srp Arh Celok Lek. 2015 Jul-Aug;143(7-8):458-63. doi: 10.2298/sarh1508458t.
9
Pediatric inflammatory myofibroblastic tumor with late metastasis to the lung: case report and review of the literature.小儿炎性肌纤维母细胞瘤伴晚期肺转移：病例报告及文献复习
Pediatr Dev Pathol. 2005 Mar-Apr;8(2):224-9. doi: 10.1007/s10024-004-8088-5. Epub 2005 Mar 8.
10
Inflammatory myofibroblastic tumor in lung with osteopulmonary arthropathy.
Chin Med J (Engl). 2009 Dec 20;122(24):3094-6.

引用本文的文献

1
Inflammatory myofibroblastic tumor of the lung: a comprehensive narrative review of clinical and therapeutic insights.肺炎性肌纤维母细胞瘤：临床与治疗见解的全面叙述性综述
Kardiochir Torakochirurgia Pol. 2025 Mar;22(1):32-43. doi: 10.5114/kitp.2025.148514. Epub 2025 Mar 14.

本文引用的文献

1
Inflammatory Myofibroblastic Tumor: A Rare Presentation and an Effective Treatment with Crizotinib.炎性肌纤维母细胞瘤：一种罕见表现及克唑替尼的有效治疗
Case Rep Oncol Med. 2020 Jul 9;2020:6923103. doi: 10.1155/2020/6923103. eCollection 2020.
2
Inflammatory Myofibroblastic Tumor of the Lung: An Extremely Rare Condition in Adults.肺炎性肌纤维母细胞瘤：成人极为罕见的病症。
Cureus. 2019 Dec 20;11(12):e6432. doi: 10.7759/cureus.6432.
3
How long should we continue crizotinib in ALK translocation-positive inflammatory myofibroblastic tumors? Long-term complete response with crizotinib and review of the literature.
在ALK易位阳性的炎性肌纤维母细胞瘤中，我们应该持续使用克唑替尼多长时间？克唑替尼治疗的长期完全缓解及文献综述。
J Oncol Pharm Pract. 2020 Jun;26(4):1011-1018. doi: 10.1177/1078155219879757. Epub 2019 Oct 15.
4
Crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumours with and without anaplastic lymphoma kinase gene alterations (European Organisation for Research and Treatment of Cancer 90101 CREATE): a multicentre, single-drug, prospective, non-randomised phase 2 trial.克唑替尼治疗有和无间变性淋巴瘤激酶基因改变的不可切除的晚期炎症性肌纤维母细胞瘤患者（欧洲癌症研究与治疗组织 90101 CREATE）：一项多中心、单药、前瞻性、非随机 2 期试验。
Lancet Respir Med. 2018 Jun;6(6):431-441. doi: 10.1016/S2213-2600(18)30116-4. Epub 2018 Apr 15.
5
Efficiency of Crizotinib on an ALK-Positive Inflammatory Myofibroblastic Tumor of the Central Nervous System: A Case Report.克唑替尼治疗ALK阳性中枢神经系统炎性肌纤维母细胞瘤的疗效：一例报告
Cureus. 2017 Mar 2;9(3):e1068. doi: 10.7759/cureus.1068.
6
Chromoplectic TPM3-ALK rearrangement in a patient with inflammatory myofibroblastic tumor who responded to ceritinib after progression on crizotinib.一名炎性肌纤维母细胞瘤患者发生了染色体复杂的TPM3-ALK重排，该患者在克唑替尼治疗进展后对色瑞替尼有反应。
Ann Oncol. 2016 Nov;27(11):2111-2117. doi: 10.1093/annonc/mdw405. Epub 2016 Oct 14.
7
WHO classification of soft tissue tumours: an update based on the 2013 (4th) edition.世界卫生组织软组织肿瘤分类：基于 2013 年（第 4 版）的更新。
Pathology. 2014 Feb;46(2):95-104. doi: 10.1097/PAT.0000000000000050.
8
ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor.炎症性肌纤维母细胞瘤中ALK1和p80的表达以及涉及2p23的染色体重排
Mod Pathol. 2001 Jun;14(6):569-76. doi: 10.1038/modpathol.3880352.